adquisición del fármaco Alyftrek® 125mg/50mg/10mg comp rec con película, 56 comprimidos y Alyftrek® 50mg/20mg/4mg comp rec con película, 84 comprimidos (Deutivacaftor/Tezacaftor/Vanzacaftor)
TED · 644849-2026Award noticeawardedNo deadline given
Value
Estimated€2,768,198 · 2,768,198.44 EUR
Awarded€2,768,198 · 2,768,198.44 EUR
WinnerVERTEX PHARMACEUTICALS SPAIN, S.L.
Who already wins at this buyer
Firms with recorded awards from HOSPITAL UNIVERSITARIO RAMÓN Y CAJAL in this tender’s CPV categories — the incumbents you are bidding against.
| Firm | Wins | Awarded | Last win |
|---|---|---|---|
| JANSSEN CILAG S.A | 3 | €2,351,724 | 2026-07-30 |
| ROCHE FARMA SAU | 2 | €3,678,270 | 2026-07-07 |
| VERTEX PHARMACEUTICALS SPAIN, S.L. | 2 | €3,437,267 | 2026-09-16 |
| BRISTOL MYERS SQUIBB S.A.U. | 1 | €2,823,840 | 2026-06-24 |
| SANOFI-AVENTIS S.A | 1 | €893,669 | 2026-07-28 |
Full buyer profile: what HOSPITAL UNIVERSITARIO RAMÓN Y CAJAL buys and who wins it →
CPV codes
33673000 Medical equipment & pharmaceuticalsDescription
adquisición del fármaco Alyftrek® 125mg/50mg/10mg comp rec con película, 56 comprimidos y Alyftrek® 50mg/20mg/4mg comp rec con película, 84 comprimidos (Deutivacaftor/Tezacaftor/Vanzacaftor), con destino al Servicio de Farmacia del Hospital Universitario Ramón y Cajal
Similar tenders
Closest by meaning — across languages, via embeddings.